177 related articles for article (PubMed ID: 25847751)
1. ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis.
Breitenstein B; Brückl TM; Ising M; Müller-Myhsok B; Holsboer F; Czamara D
Am J Med Genet B Neuropsychiatr Genet; 2015 Jun; 168B(4):274-83. PubMed ID: 25847751
[TBL] [Abstract][Full Text] [Related]
2. ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study.
Magarbeh L; Hassel C; Choi M; Islam F; Marshe VS; Zai CC; Zuberi R; Gammal RS; Men X; Scherf-Clavel M; Enko D; Frey BN; Milev R; Soares CN; Parikh SV; Placenza F; Strother SC; Hassel S; Taylor VH; Leri F; Blier P; Farzan F; Lam RW; Turecki G; Foster JA; Rotzinger S; Kloiber S; Kennedy JL; Kennedy SH; Bousman CA; Müller DJ
Clin Pharmacol Ther; 2023 Jul; 114(1):88-117. PubMed ID: 36681895
[TBL] [Abstract][Full Text] [Related]
3. Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study.
Breitenstein B; Scheuer S; Brückl TM; Meyer J; Ising M; Uhr M; Holsboer F
J Psychiatr Res; 2016 Feb; 73():86-95. PubMed ID: 26704739
[TBL] [Abstract][Full Text] [Related]
4. ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder.
de Klerk OL; Nolte IM; Bet PM; Bosker FJ; Snieder H; den Boer JA; Bruggeman R; Hoogendijk WJ; Penninx BW
Pharmacogenomics J; 2013 Aug; 13(4):349-53. PubMed ID: 22641028
[TBL] [Abstract][Full Text] [Related]
5. The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.
Breitenstein B; Scheuer S; Pfister H; Uhr M; Lucae S; Holsboer F; Ising M; Brückl TM
CNS Spectr; 2014 Apr; 19(2):165-75. PubMed ID: 23880209
[TBL] [Abstract][Full Text] [Related]
6. ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.
Ray A; Tennakoon L; Keller J; Sarginson JE; Ryan HS; Murphy GM; Lazzeroni LC; Trivedi MH; Kocsis JH; DeBattista C; Schatzberg AF
Pharmacogenomics J; 2015 Aug; 15(4):332-9. PubMed ID: 25487678
[TBL] [Abstract][Full Text] [Related]
7. Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design.
Geers LM; Ochi T; Vyalova NM; Losenkov IS; Paderina DZ; Pozhidaev IV; Simutkin GG; Bokhan NA; Wilffert B; Touw DJ; Loonen AJM; Ivanova SA
Hum Psychopharmacol; 2022 May; 37(3):e2826. PubMed ID: 34788473
[TBL] [Abstract][Full Text] [Related]
8. ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.
Singh AB; Bousman CA; Ng CH; Byron K; Berk M
Transl Psychiatry; 2012 Nov; 2(11):e198. PubMed ID: 23188198
[TBL] [Abstract][Full Text] [Related]
9. ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression.
Sarginson JE; Lazzeroni LC; Ryan HS; Ershoff BD; Schatzberg AF; Murphy GM
Pharmacogenet Genomics; 2010 Aug; 20(8):467-75. PubMed ID: 20555295
[TBL] [Abstract][Full Text] [Related]
10.
Santos M; Lima L; Carvalho S; Brandão A; Barroso F; Cruz A; Medeiros R
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791151
[TBL] [Abstract][Full Text] [Related]
11. Case-control association study of ABCB1 gene and major depressive disorder in a local Chinese Han population.
Xie WW; Zhang L; Wu RR; Yu Y; Zhao JP; Li LH
Neuropsychiatr Dis Treat; 2015; 11():1967-71. PubMed ID: 26347319
[TBL] [Abstract][Full Text] [Related]
12. Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder.
Simoons M; Mulder H; Appeldoorn JTY; Risselada AJ; Schene AH; van Schaik RHN; van Roon EN; Ruhé EG
Psychiatr Genet; 2020 Feb; 30(1):19-29. PubMed ID: 31634334
[TBL] [Abstract][Full Text] [Related]
13. ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.
Kato M; Fukuda T; Serretti A; Wakeno M; Okugawa G; Ikenaga Y; Hosoi Y; Takekita Y; Mandelli L; Azuma J; Kinoshita T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):398-404. PubMed ID: 17913323
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas.
Athanasoulia AP; Sievers C; Ising M; Brockhaus AC; Yassouridis A; Stalla GK; Uhr M
Eur J Endocrinol; 2012 Sep; 167(3):327-35. PubMed ID: 22672924
[TBL] [Abstract][Full Text] [Related]
15. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
Dong C; Wong ML; Licinio J
Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206
[TBL] [Abstract][Full Text] [Related]
16. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM
Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420
[TBL] [Abstract][Full Text] [Related]
17. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics in major depression: a comprehensive meta-analysis.
Niitsu T; Fabbri C; Bentini F; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():183-94. PubMed ID: 23733030
[TBL] [Abstract][Full Text] [Related]
19. Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.
Fujii T; Ota M; Hori H; Sasayama D; Hattori K; Teraishi T; Yamamoto N; Hashikura M; Tatsumi M; Higuchi T; Kunugi H
J Psychiatr Res; 2012 Apr; 46(4):555-9. PubMed ID: 22306099
[TBL] [Abstract][Full Text] [Related]
20. ABCB1/MDR1 gene polymorphism and colorectal cancer risk: a meta-analysis of case-control studies.
He T; Mo A; Zhang K; Liu L
Colorectal Dis; 2013 Jan; 15(1):12-8. PubMed ID: 23279665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
